HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Clinical trials for HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA explained in plain language.
Never miss a new study
Get alerted when new HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA trials appear
Sign up with your email to follow new studies for HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cholesterol drug inclisiran tested in Real-World spanish patients
Disease control Recruiting nowThis study follows 200 adults in Spain who are already taking inclisiran (Leqvio) for heart disease or a genetic high-cholesterol condition. Researchers want to see if the drug helps patients reach their LDL cholesterol goals in everyday medical practice. The study is observation…
Matched conditions: HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 06:49 UTC
-
Gene editing breakthrough targets stubborn high cholesterol
Disease control Recruiting nowThis study tests a new gene editing treatment called VERVE-102 for people with inherited high cholesterol or early heart disease who need extra help lowering their LDL cholesterol. The treatment aims to turn off a gene in the liver to reduce cholesterol levels. The study involves…
Matched conditions: HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Phase: PHASE1 • Sponsor: Verve Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 04:38 UTC